FBIO Fortress Biotech, Inc. - Common Stock
Tentang Fortress Biotech, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
Baca selengkapnya
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
History
The company was founded in 2006 under the name Coronado Biosciences, initially as an oncology company. In 2011, it was announced that Coronado raised $47.4 million in funding. Shortly thereafter it became a public company by registering all of its private shares as common stock. The company changed its name to Fortress Biotech in April 2015.
In November 2019, Fortress Biotech was ranked number 10 in the 2019 Deloitte Technology Fast 500 annual rankings.
Subsidiaries
Fortress Bio has 10 biopharmaceutical subsidiary companies which cover a range of medical therapy areas, including potential cancer treatments and therapies for rare diseases and conditions. These subsidiaries include Aevitas Therapeutics (formed in 2017), Avenue Therapeutics (formed in 2015), Caelum Biosciences (formed in 2017), Cellvation (formed in 2016), Checkpoint Therapeutics (formed in 2015), Cyprium Therapeutics (formed in 2017), Helocyte (formed in 2015), Journey Medical Corporation (formed in 2014), Mustang Bio (formed in 2015), Tamid Bio (formed in 2017) and Baergic Bio (formed in 2019).
Products
Fortress Bio’s marketed products are developed and commercialized by its subsidiary Journey Medical Corporation. These include Targadox tablets indicated for acne, eczema emollient Ceracade, wound cream Luxamend, topical corticosteroid Triderm, topical broad-spectrum antifungal solution Exelderm, Ala-Quin topical cream for skin conditions, and Ala-Scalp hydrocortisone lotion for skin conditions.
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
FBIO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
FBIO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
FBIO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 2 25,0%
- Beli 5 62,5%
- Tahan 1 12,5%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
2 analis · 2026-08-18Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-1.13 | $-0.22 | -0.91% |
| 31 Des. 2025 | $-0.01 | $0.11 | -0.12% |
| 30 Sep. 2025 | $0.11 | $-0.43 | 0.54% |
| 30 Juni 2025 | $-0.50 | $-0.37 | -0.13% |
| 31 Maret 2025 | $-0.48 | $-0.50 | 0.02% |
| 31 Des. 2024 | $-0.75 | $-0.77 | 0.02% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| FBIO | — | — | — | — | — | — |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| ALDX | $312M | -9.2 | — | — | -68.0% | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| ICCC | — | -51.2 | 4.3% | — | — | — |
| KLRS | $193M | -3.0 | — | — | -65.8% | — |
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 66 pengaju · $16.8M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 18 (+5 vs Kuartal sebelumnya) | 11 (+2 vs Kuartal sebelumnya) | 14 (+2 vs Kuartal sebelumnya) | 15 (-2 vs Kuartal sebelumnya) | +1.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3.173.841 | 1.037.203 | 18,88% | Saham |
| Opaleye Management Inc. | $2.723.400 | 890.000 | 16,20% | Saham |
| MACKENZIE FINANCIAL CORP | $1.700.369 | 555.676 | 10,11% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.089.360 | 356.000 | 6,48% | Opsi jual |
| GEODE CAPITAL MANAGEMENT, LLC | $757.798 | 247.532 | 4,51% | Saham |
| TWO SIGMA INVESTMENTS, LP | $654.185 | 213.786 | 3,89% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $542.746 | 177.368 | 3,23% | Saham |
| VANGUARD GROUP INC | $521.678 | 142.535 | 3,10% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $509.095 | 166.371 | 3,03% | Saham |
| HB Wealth Management, LLC | $357.026 | 116.675 | 2,12% | Saham |
| Kestra Advisory Services, LLC | $355.679 | 116.235 | 2,12% | Saham |
| STATE STREET CORP | $310.899 | 101.601 | 1,85% | Saham |
| GOLDMAN SACHS GROUP INC | $294.855 | 96.358 | 1,75% | Saham |
| Integrated Wealth Concepts LLC | $276.624 | 90.400 | 1,65% | Saham |
| Sheets Smith Investment Management | $270.259 | 73.142 | 1,61% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $264.353 | 86.390 | 1,57% | Saham |
| CITADEL ADVISORS LLC | $235.819 | 77.065 | 1,40% | Saham |
| Integrated Quantitative Investments LLC | $210.198 | 68.692 | 1,25% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $202.037 | 66.025 | 1,20% | Saham |
| NORTHERN TRUST CORP | $194.714 | 63.632 | 1,16% | Saham |
| 180 WEALTH ADVISORS, LLC | $188.496 | 61.600 | 1,12% | Saham |
| CITADEL ADVISORS LLC | $178.704 | 58.400 | 1,06% | Opsi jual |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $143.826 | 47.002 | 0,86% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140.148 | 45.800 | 0,83% | Opsi beli |
| WOLVERINE TRADING, LLC | $129.480 | 33.200 | 0,77% | Opsi jual |
| PRELUDE CAPITAL MANAGEMENT, LLC | $127.011 | 41.507 | 0,76% | Saham |
| WOLVERINE TRADING, LLC | $124.800 | 32.000 | 0,74% | Opsi beli |
| PFG Investments, LLC | $111.693 | 36.501 | 0,66% | Saham |
| CHOREO, LLC | $110.925 | 36.250 | 0,66% | Saham |
| JANE STREET GROUP, LLC | $93.024 | 30.400 | 0,55% | Opsi jual |
| TWO SIGMA ADVISERS, LP | $92.415 | 25.250 | 0,55% | Saham |
| JANE STREET GROUP, LLC | $77.767 | 25.414 | 0,46% | Saham |
| Cubist Systematic Strategies, LLC | $77.347 | 20.933 | 0,46% | Saham |
| Empowered Funds, LLC | $76.500 | 25.000 | 0,45% | Saham |
| Squarepoint Ops LLC | $47.066 | 15.381 | 0,28% | Saham |
| Corient Private Wealth LP | $45.787 | 14.963 | 0,27% | Saham |
| NewEdge Advisors, LLC | $45.677 | 14.927 | 0,27% | Saham |
| Abacus Planning Group, Inc. | $44.474 | 14.534 | 0,26% | Saham |
| SIMPLEX TRADING, LLC | $44.394 | 14.508 | 0,26% | Saham |
| Man Group plc | $40.940 | 13.379 | 0,24% | Saham |
| Vanguard Global Advisers, LLC | $38.489 | 12.578 | 0,23% | Saham |
| Weaver Consulting Group | $31.724 | 10.367 | 0,19% | Saham |
| Forum Financial Management, LP | $30.600 | 10.000 | 0,18% | Saham |
| OSAIC HOLDINGS, INC. | $27.725 | 9.061 | 0,16% | Saham |
| BlackRock, Inc. | $18.155 | 5.933 | 0,11% | Saham |
| WELLS FARGO & COMPANY/MN | $15.300 | 5.000 | 0,09% | Saham |
| Rockefeller Capital Management L.P. | $14.725 | 4.812 | 0,09% | Saham |
| Arax Advisory Partners | $12.503 | 4.086 | 0,07% | Saham |
| UBS Group AG | $12.240 | 4.000 | 0,07% | Saham |
| SBI Securities Co., Ltd. | $11.169 | 3.650 | 0,07% | Saham |
| Tower Research Capital LLC (TRC) | $4.296 | 1.404 | 0,03% | Saham |
| BARCLAYS PLC | $3.042 | 994 | 0,02% | Saham |
| Truvestments Capital LLC | $2.148 | 702 | 0,01% | Saham |
| ROYAL BANK OF CANADA | $2.000 | 725 | 0,01% | Saham |
| GSA CAPITAL PARTNERS LLP | $1.403 | 458.472 | 0,01% | Saham |
| JPMORGAN CHASE & CO | $982 | 333 | 0,01% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $793 | 259 | 0,00% | Saham |
| SHIKIAR ASSET MANAGEMENT INC | $409 | 133.666 | 0,00% | Saham |
| ACADIAN ASSET MANAGEMENT LLC | $327 | 107.303 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $135 | 44 | 0,00% | Saham |
| Larson Financial Group LLC | $113 | 37 | 0,00% | Saham |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $101 | 33 | 0,00% | Saham |
| Virtu Financial LLC | $76 | 24.731 | 0,00% | Saham |
| Axiom Investment Management LLC | $52 | 17 | 0,00% | Saham |
| MORGAN STANLEY | $3 | 1 | 0,00% | Saham |
| Motiv8 Investments LLC | $0 | 33 | 0,00% | Saham |
Orang dalam perusahaan 22 orang dalam · 11 pejabat · 13 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | PRESIDENT, CEO & CHAIRMAN | 18 Maret 2026 A | 4.586.841 | 0 | 0 | $0 |
| Harlan F Weisman | Chairman and CEO | 20 Juni 2013 P | 30.000 | 0 | 0 | $0 |
| David Jin | Chief Financial Officer | 10 Juli 2024 P | 500 | 0 | 0 | $0 |
| Robyn Hunter | Chief Financial Officer | 21 Sep. 2021 S | 163.877 | 0 | 0 | $0 |
| Bobby W Sandage PHD | President | 5 April 2013 G | 22.311 | 0 | 0 | $0 |
| Noah D Beerman | Executive VP and COO | 31 Mei 2013 P | 15.000 | 0 | 0 | $0 |
| Michael S Weiss | Executive Vice Chairman | 18 Maret 2026 A | 2.276.562 | 0 | 0 | $0 |
| George Avgerinos | SVP, BIOLOGICS OPERATIONS | 17 April 2019 A | 655.170 | 0 | 0 | $0 |
| Dale Ritter | SVP & Chief Accounting Officer | 31 Mei 2013 P | 11.503 | 0 | 0 | $0 |
| Glenn L Cooper MD | Executive Chairman of the Board | 30 Nov. 2012 P | 43.811 | 0 | 0 | $0 |
| Karin M. Hehenberger | Executive Vice President; Chief Medical Officer | 22 Juni 2012 P | 20.925 | 0 | 0 | $0 |
| Jay J Lobell | Direktur | 1 Jan. 2026 A | 192.397 | 0 | 0 | $0 |
| Dov Klein | Direktur | 20 Mei 2024 S | 53.400 | 0 | 0 | $0 |
| Kevin Lorenz | Direktur | 1 Jan. 2024 A | 24.304 | 0 | 0 | $0 |
| Lucy Lu | Direktur | 1 Jan. 2024 A | 11.890 | 0 | 0 | $0 |
| Jimmie Harvey | Direktur | 1 Jan. 2024 A | 69.999 | 0 | 0 | $0 |
| Eric K Rowinsky | Direktur | 1 Jan. 2024 A | 68.797 | 0 | 0 | $0 |
| David Jonathan Barrett | Direktur | 20 Feb. 2014 A | 50.000 | 0 | 0 | $0 |
| Michael W Rogers | Direktur | 7 Feb. 2013 A | — | 0 | 0 | $0 |
| Fortress Biotech, Inc. | Pemilik 10% | 27 Juni 2024 A | 2.502.991 | 0 | 0 | $0 |
| Malcolm Hoenlein | — | 1 Jan. 2026 A | 115.747 | 0 | 0 | $0 |
| Kevin Horgan | — | 22 April 2014 M | 0 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. ×3 pengajuan | 20 Maret 2026 | 0,00% | Amandemen | — | SEC |
| Fortress Biotech, Inc. ×30 pengajuan | 6 Jan. 2026 | 13,40% | Amandemen | — | SEC |
| Lindsay A Rosenwald, M.D. ×2 pengajuan | 3 Jan. 2024 | — | Pengajuan awal | — | SEC |
| Michael S. Weiss ×4 pengajuan | 21 Nov. 2023 | — | Pengajuan awal | — | SEC |
| Mr. Daryl Katz, DAK Capital Inc. ×2 pengajuan | 14 Feb. 2023 | — | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 3 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.